These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11953329)

  • 1. Cyclooxygenase inhibition: between the devil and the deep blue sea.
    Hawkey CJ
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 4. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract]   [Full Text] [Related]  

  • 6. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with preferential and specific COX-2 inhibitors].
    Stichtenoth DO; Frölich JC
    Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
    Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
    [No Abstract]   [Full Text] [Related]  

  • 10. Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.
    Micklewright R; Lane S; Linley W; McQuade C; Thompson F; Maskrey N
    Aliment Pharmacol Ther; 2003 Feb; 17(3):321-32. PubMed ID: 12562444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
    Brater DC
    Am J Med; 1999 Dec; 107(6A):65S-70S; discussion 70S-71S. PubMed ID: 10628595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 13. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
    Jüni P; Rutjes AW; Dieppe PA
    BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular events and COX-2 inhibitors.
    Fleming M
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract]   [Full Text] [Related]  

  • 15. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 16. COX-2 inhibitors and Celebrex: safe or suspect?
    Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
    Hinz B; Brune K
    MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA refuses companies' request to drop ulcer warning.
    Gottlieb S
    BMJ; 2001 Feb; 322(7283):385. PubMed ID: 11179151
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective inhibitors of COX-2--are they safe for the stomach?
    Giercksky KE; Haglund U; Rask-Madsen J
    Scand J Gastroenterol; 2000 Nov; 35(11):1121-4. PubMed ID: 11145280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors.
    Buttgereit F; Burmester GR; Simon LS
    Am J Med; 2001 Feb; 110 Suppl 3A():13S-9S. PubMed ID: 11173045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.